Lexicon Pharmaceuticals Inc
NASDAQ:LXRX

Watchlist Manager
Lexicon Pharmaceuticals Inc Logo
Lexicon Pharmaceuticals Inc
NASDAQ:LXRX
Watchlist
Price: 1.21 USD 0.83% Market Closed
Market Cap: 439.4m USD

Profitability Summary

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Past Growth

Analyzing past growth in Revenue, Operating Income, and Net Income allows investors to assess the company's profitability and operational efficiency. Consistent improvement in these metrics typically signals long-term strength and stability.

Show More Less

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Show More Less

Earnings Waterfall
Lexicon Pharmaceuticals Inc

Revenue
31.2m USD
Cost of Revenue
-615k USD
Gross Profit
30.6m USD
Operating Expenses
-208.1m USD
Operating Income
-177.5m USD
Other Expenses
162k USD
Net Income
-177.3m USD

Margins Comparison
Lexicon Pharmaceuticals Inc Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
US
Lexicon Pharmaceuticals Inc
NASDAQ:LXRX
439.4m USD
98%
-569%
-568%
FR
Pharnext SCA
OTC:PNEXF
6T USD
0%
-17 527%
-21 040%
US
Abbvie Inc
NYSE:ABBV
337.1B USD
71%
30%
7%
US
Cyclo Therapeutics Inc
NASDAQ:CYTH
325.9B USD
91%
-2 834%
-2 848%
US
Amgen Inc
NASDAQ:AMGN
165.2B USD
64%
25%
17%
US
Gilead Sciences Inc
NASDAQ:GILD
145.3B USD
78%
38%
21%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
120.8B USD
86%
38%
-9%
US
Epizyme Inc
F:EPE
94.1B EUR
76%
-370%
-392%
AU
CSL Ltd
ASX:CSL
130.4B AUD
52%
26%
18%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
61.3B USD
87%
29%
32%
US
Seagen Inc
F:SGT
39.3B EUR
75%
-33%
-33%

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Show More Less

Return on Capital Comparison
Lexicon Pharmaceuticals Inc Competitors

Country Company Market Cap ROE ROA ROCE ROIC
US
Lexicon Pharmaceuticals Inc
NASDAQ:LXRX
439.4m USD
-86%
-50%
-61%
-244%
FR
Pharnext SCA
OTC:PNEXF
6T USD
115%
-391%
275%
3 093%
US
Abbvie Inc
NYSE:ABBV
337.1B USD
88%
3%
17%
20%
US
Cyclo Therapeutics Inc
NASDAQ:CYTH
325.9B USD
341%
-457%
341%
1 155%
US
Amgen Inc
NASDAQ:AMGN
165.2B USD
106%
7%
12%
10%
US
Gilead Sciences Inc
NASDAQ:GILD
145.3B USD
33%
11%
25%
19%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
120.8B USD
-6%
-4%
21%
94%
US
Epizyme Inc
F:EPE
94.1B EUR
-877%
-67%
-73%
-182%
AU
CSL Ltd
ASX:CSL
130.4B AUD
15%
7%
12%
9%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
61.3B USD
16%
13%
13%
14%
US
Seagen Inc
F:SGT
39.3B EUR
-28%
-21%
-27%
-39%

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

Show More Less